The effectiveness of Cholestimide on dyslipidemia with visceral fat accumulation in patients with type 2 diabetes. A randomized parallel crossover trial
Not Applicable
- Conditions
- Type 2 Diabetes, Dyslipidemia
- Registration Number
- JPRN-UMIN000011218
- Lead Sponsor
- Tokyo Women's Medical University, Diabetes Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
Not provided
Exclusion Criteria
Patients with complete biliary obstruction Patients with hypersensitivity to cholestimide or past history of ileus. Patients with poor control of constipation Patients who take warfarin, tetracycline, Phenobarbital, thyroid gland preparation, digitalis Patients with unstable proliferative diabetic retinopathy Patients whose stage of diabetic nephropathy is above stage 4 Patients who have active infection or are under treatment of malignancy Patients who have macroangiopathy Patients who are considered to be inadequate to participate in this study.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Visceral fat area
- Secondary Outcome Measures
Name Time Method 1. Resting energy expenditure, Respiratory quotient 2. HbA1c, blood glucose, Insulin secretion 3.lipid metabolism 4.oxidative stress